|
1
|
Vivo Capital
Palo Alto,
California
|
$107M
|
+$40.5M
|
+1,412,437
|
+74%
|
|
|
2
|
Frazier Life Sciences Management
Palo Alto,
California
|
$75.1M
|
+$67.2M
|
+2,342,198
|
New
|
|
|
3
|
|
$63M
|
+$14M
|
+487,450
|
+33%
|
|
|
4
|
Abingworth
London,
United Kingdom
|
$42.1M
|
+$12.5M
|
+437,356
|
+50%
|
|
|
5
|
Rock Springs Capital Management
Baltimore,
Maryland
|
$37.7M
|
-$287K
|
-10,007
|
-0.8%
|
|
|
6
|
PFM Health Sciences
San Francisco,
California
|
$34.1M
|
+$30.5M
|
+1,062,888
|
New
|
|
|
7
|
Adage Capital Partners
Boston,
Massachusetts
|
$32M
|
-$6.61M
|
-230,468
|
-19%
|
|
|
8
|
Paradigm Biocapital Advisors
New York
|
$24.7M
|
+$8.5M
|
+296,369
|
+62%
|
|
|
9
|
Sofinnova Investments
Menlo Park,
California
|
$18.3M
|
+$10.3M
|
+360,016
|
+170%
|
|
|
10
|
Citadel Advisors
Miami,
Florida
|
$15M
|
+$13.4M
|
+467,809
|
New
|
|
|
11
|
|
$14.4M
|
+$12.2M
|
+424,985
|
+1,813%
|
|
|
12
|
Silverarc Capital Management
Boston,
Massachusetts
|
$14.2M
|
+$7.21M
|
+251,336
|
+131%
|
|
|
13
|
|
$14.1M
|
+$12.7M
|
+441,005
|
New
|
|
|
14
|
Laurion Capital Management
New York
|
$13.6M
|
+$12.2M
|
+425,000
|
New
|
|
|
15
|
Vanguard Group
Malvern,
Pennsylvania
|
$11.9M
|
+$2.79M
|
+97,391
|
+35%
|
|
|
16
|
Ghost Tree Capital
New York
|
$10.4M
|
+$2.15M
|
+75,000
|
+30%
|
|
|
17
|
Tang Capital Management
San Diego,
California
|
$9.62M
|
+$8.61M
|
+300,000
|
New
|
|
|
18
|
Two Sigma Investments
New York
|
$9.61M
|
+$7.1M
|
+247,437
|
+471%
|
|
|
19
|
Marshall Wace
London,
United Kingdom
|
$9.13M
|
+$8.17M
|
+284,781
|
New
|
|
|
20
|
Two Sigma Advisers
New York
|
$8.22M
|
+$5.59M
|
+194,800
|
+315%
|
|
|
21
|
Ikarian Capital
Dallas,
Texas
|
$6.98M
|
-$10.1M
|
-351,114
|
-62%
|
|
|
22
|
Kynam Capital Management
Princeton,
New Jersey
|
$6.2M
|
+$5.55M
|
+193,280
|
New
|
|
|
23
|
|
$5.34M
|
+$4.78M
|
+166,550
|
New
|
|
|
24
|
|
$5.21M
|
+$4.66M
|
+162,479
|
New
|
|
|
25
|
Parkman Healthcare Partners
Stamford,
Connecticut
|
$4.87M
|
+$4.36M
|
+151,915
|
New
|
|
